The University of Southampton
University of Southampton Institutional Repository

Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up

Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up
Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up
Background: this study compared the efficacy of an elemental formula (EF) to a polymeric formula (PF) in inducing remission for pediatric Crohn's disease (CD).

Methods: newly diagnosed CD children were randomized to EF or PF for 6 weeks. Change in the Pediatric Crohn's Disease Activity Index (PCDAI), fecal calprotectin, and plasma fatty acids were measured at 0 and 6 weeks. Patients were followed up for 2 years. Time and treatment choice for first relapse were documented.

Results: thirty-four children completed the study; EF: 15 (7 M, 8 F), PF: 19 (13 M, 6 F). The mean age was (years) EF: 12.6, PF: 11.7. Ninety-three percent of children (14/15) achieved remission in the EF group and 79% (15/19) in the PF group. One-third of patients maintained remission for 2 years. Mean time to relapse (days); EF: 183 (63-286), PF: 162 (53-301). Most children who relapsed used feed as a treatment for that relapse (EF: 9/10 and PF: 8/13). With PF, an increase of eicosapentanoic acid (EPA) and alpha linolenic acid was found with a reciprocal decrease in arachidonic acid (AA). With EF, AA and EPA levels were reduced with a significant decrease in docosahexaenoic acid. Fecal calprotectin measurements decreased significantly but did not normalize at the end of week 6.

Conclusions: there was no significant difference between EF and PF in inducing remission. One-third of children maintained remission. Changes in plasma polyunsaturated fatty acid status were subtle and may be relevant; however, further evaluation is recommended
Grogan, Joanne L.
94aeb1b4-771d-4231-b650-11d888cfcab4
Casson, David H.
ee40b3fa-241d-4a40-a1c8-9449525a3675
Terry, Allyson
9464b5e1-d63d-48a4-89dd-b8a48865af2c
Burdge, Graham C.
09d60a07-8ca1-4351-9bf1-de6ffcfb2159
El-Matary, Wael
f0281071-64f1-4ae8-a77e-4f04aebd78a6
Dalzell, A. Mark
a7cd0e8d-37e4-4958-98a9-1ef3ec980f4a
Grogan, Joanne L.
94aeb1b4-771d-4231-b650-11d888cfcab4
Casson, David H.
ee40b3fa-241d-4a40-a1c8-9449525a3675
Terry, Allyson
9464b5e1-d63d-48a4-89dd-b8a48865af2c
Burdge, Graham C.
09d60a07-8ca1-4351-9bf1-de6ffcfb2159
El-Matary, Wael
f0281071-64f1-4ae8-a77e-4f04aebd78a6
Dalzell, A. Mark
a7cd0e8d-37e4-4958-98a9-1ef3ec980f4a

Grogan, Joanne L., Casson, David H., Terry, Allyson, Burdge, Graham C., El-Matary, Wael and Dalzell, A. Mark (2011) Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up. Inflammatory Bowel Diseases. (doi:10.1002/ibd.21690). (PMID:21425210)

Record type: Article

Abstract

Background: this study compared the efficacy of an elemental formula (EF) to a polymeric formula (PF) in inducing remission for pediatric Crohn's disease (CD).

Methods: newly diagnosed CD children were randomized to EF or PF for 6 weeks. Change in the Pediatric Crohn's Disease Activity Index (PCDAI), fecal calprotectin, and plasma fatty acids were measured at 0 and 6 weeks. Patients were followed up for 2 years. Time and treatment choice for first relapse were documented.

Results: thirty-four children completed the study; EF: 15 (7 M, 8 F), PF: 19 (13 M, 6 F). The mean age was (years) EF: 12.6, PF: 11.7. Ninety-three percent of children (14/15) achieved remission in the EF group and 79% (15/19) in the PF group. One-third of patients maintained remission for 2 years. Mean time to relapse (days); EF: 183 (63-286), PF: 162 (53-301). Most children who relapsed used feed as a treatment for that relapse (EF: 9/10 and PF: 8/13). With PF, an increase of eicosapentanoic acid (EPA) and alpha linolenic acid was found with a reciprocal decrease in arachidonic acid (AA). With EF, AA and EPA levels were reduced with a significant decrease in docosahexaenoic acid. Fecal calprotectin measurements decreased significantly but did not normalize at the end of week 6.

Conclusions: there was no significant difference between EF and PF in inducing remission. One-third of children maintained remission. Changes in plasma polyunsaturated fatty acid status were subtle and may be relevant; however, further evaluation is recommended

This record has no associated files available for download.

More information

e-pub ahead of print date: March 2011

Identifiers

Local EPrints ID: 180915
URI: http://eprints.soton.ac.uk/id/eprint/180915
PURE UUID: 3cfba37e-6fdc-435e-93b3-76f54552a0db
ORCID for Graham C. Burdge: ORCID iD orcid.org/0000-0002-7665-2967

Catalogue record

Date deposited: 13 Apr 2011 13:57
Last modified: 14 Mar 2024 02:54

Export record

Altmetrics

Contributors

Author: Joanne L. Grogan
Author: David H. Casson
Author: Allyson Terry
Author: Wael El-Matary
Author: A. Mark Dalzell

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×